Bionorica SE
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Subsidiary
- Established
- 1933-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.bionorica.de
Clinical Trials
28
Active:15
Completed:11
Trial Phases
4 Phases
Phase 1:8
Phase 2:1
Phase 3:9
+1 more phases
Drug Approvals
7
CIMA_AEMPS:7
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials
Phase 3
9 (42.9%)Phase 1
8 (38.1%)Not Applicable
3 (14.3%)Phase 2
1 (4.8%)Efficacy of Vitex Agnus-castus BNO 1095 (20 mg) in Women With Primary Dysmenorrhea
Phase 3
Completed
- Conditions
- Primary Dysmenorrhea
- Interventions
- Drug: PlaceboDrug: Vitex agnus-castus BNO 1095 (20 mg)
- First Posted Date
- 2024-01-18
- Last Posted Date
- 2025-07-28
- Lead Sponsor
- Bionorica SE
- Target Recruit Count
- 335
- Registration Number
- NCT06211049
- Locations
- 🇦🇹
Medizinische Universität Innsbruck, Department Frauenheilkunde, Universitätsklinik für Gynäkologische Endokrinologie und Reproduktionsmedizin, Innsbruck, Austria
🇦🇹Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin, Wien, Austria
🇨🇿Centrum ambulantní gynekologie a primární péče s.r.o., Brno Střed, Czechia
Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 5 Days of Use on Subjects With Atopic Dermatitis
Not Applicable
Completed
- Conditions
- Atopic DiathesisEczema-prone Skin
- First Posted Date
- 2023-04-11
- Last Posted Date
- 2023-04-11
- Lead Sponsor
- Bionorica SE
- Target Recruit Count
- 44
- Registration Number
- NCT05807113
- Locations
- 🇩🇪
SGS proderm GmbH, Schenefeld, Germany
Skin Efficacy and Tolerability of a Cosmetic Product Combination Over 3 Months in Subjects With Atopic Eczema
Not Applicable
Active, not recruiting
- Conditions
- Atopic DermatitisEczema-Prone Skin
- First Posted Date
- 2023-03-29
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- Bionorica SE
- Target Recruit Count
- 100
- Registration Number
- NCT05790083
- Locations
- 🇩🇪
SGS proderm GmbH, Schenefeld, Germany
Assessment of Skin Tolerance and Efficacy of a Cosmetic Product After 4 Weeks of Use on Subjects With Atopic Dermatitis
Not Applicable
Completed
- Conditions
- Atopic DiathesisEczema-Prone Skin
- First Posted Date
- 2023-03-28
- Last Posted Date
- 2023-03-28
- Lead Sponsor
- Bionorica SE
- Target Recruit Count
- 44
- Registration Number
- NCT05786976
- Locations
- 🇩🇪
SGS proderm GmbH, Schenefeld, Germany
BX-1 in Spasticity Due to Multiple Sclerosis
- First Posted Date
- 2018-11-28
- Last Posted Date
- 2021-05-05
- Lead Sponsor
- Bionorica SE
- Target Recruit Count
- 397
- Registration Number
- NCT03756974
- Locations
- 🇪🇸
Investigative Site, Valencia, Spain
🇨🇿Investigative site, Hradec Králové, Czechia
- Prev
- 1
- 2
- 3
- Next
News
No news found